γδIL17 under control

In the mouse, γδ IL17 cells are poised to make IL-17, and these cells have been involved in various infection and cancer models. Edwards et al. (2022. J. Exp. Med. https://doi.org/10.1084/jem.20211431) now report how different γδIL17 subsets are controlled during homeostasis and cancer.

Detalles Bibliográficos
Autores principales: Sanchez Sanchez, Guillem, Vermijlen, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2022
Materias:
Insights
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757838/
https://www.ncbi.nlm.nih.gov/pubmed/36520517
http://dx.doi.org/10.1084/jem.20221921
_version_ 1784851909570461696
author Sanchez Sanchez, Guillem
Vermijlen, David
author_facet Sanchez Sanchez, Guillem
Vermijlen, David
author_sort Sanchez Sanchez, Guillem
collection PubMed
description In the mouse, γδ IL17 cells are poised to make IL-17, and these cells have been involved in various infection and cancer models. Edwards et al. (2022. J. Exp. Med. https://doi.org/10.1084/jem.20211431) now report how different γδIL17 subsets are controlled during homeostasis and cancer.
format Online
Article
Text
id pubmed-9757838
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-97578382023-06-15 γδIL17 under control Sanchez Sanchez, Guillem Vermijlen, David J Exp Med Insights In the mouse, γδ IL17 cells are poised to make IL-17, and these cells have been involved in various infection and cancer models. Edwards et al. (2022. J. Exp. Med. https://doi.org/10.1084/jem.20211431) now report how different γδIL17 subsets are controlled during homeostasis and cancer. Rockefeller University Press 2022-12-15 /pmc/articles/PMC9757838/ /pubmed/36520517 http://dx.doi.org/10.1084/jem.20221921 Text en © 2022 Sanchez Sanchez and Vermijlen https://creativecommons.org/licenses/by-nc-sa/4.0/http://www.rupress.org/terms/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Insights
Sanchez Sanchez, Guillem
Vermijlen, David
γδIL17 under control
title γδIL17 under control
title_full γδIL17 under control
title_fullStr γδIL17 under control
title_full_unstemmed γδIL17 under control
title_short γδIL17 under control
title_sort γδil17 under control
topic Insights
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757838/
https://www.ncbi.nlm.nih.gov/pubmed/36520517
http://dx.doi.org/10.1084/jem.20221921
work_keys_str_mv AT sanchezsanchezguillem gdil17undercontrol
AT vermijlendavid gdil17undercontrol

Ejemplares similares